Krejbich Paula, Birringer Marc
Department of Nutritional, Food and Consumer Sciences, Fulda University of Applied Sciences, Leipziger Straße 123, 36037 Fulda, Germany.
Wissenschaftliches Zentrum für Ernährung, Lebensmittel und Nachhaltige Versorgungssysteme (ELVe), Fulda University of Applied Sciences, Leipziger Straße 123, 36037 Fulda, Germany.
Antioxidants (Basel). 2022 Oct 30;11(11):2149. doi: 10.3390/antiox11112149.
Complementary and alternative medicine (CAM) supplements are widely used by cancer patients. Dietary supplements, vitamins and minerals, herbal remedies, and antioxidants are especially popular. In a systematic literature review, 37 studies, each including more than 1000 participants, on CAM, dietary supplement, and vitamin use among cancer patients were identified. Accordingly, cancer patients use antioxidants such as vitamin C (from 2.6% (United Kingdom) to 41.6% (United States)) and vitamin E (from 2.9% (China) to 48% (United States)). Dietary supplements and vitamins are taken for different reasons, but often during conventional cancer treatment involving chemotherapy or radiotherapy and in a self-decided manner without seeking medical advice from healthcare professionals. Drug-drug interactions with dietary supplements or vitamins involving multiple signaling pathways are well described. Since most of the anticancer drugs generate reactive oxygen species (ROS), an adaptive stress response of healthy and malignant cells, mainly driven by the Nrf-2-Keap I network, can be observed. On the one hand, healthy cells should be protected from ROS-overproducing chemotherapy and radiotherapy; on the other hand, ROS production in cancer cells is a "desirable side effect" during anticancer drug treatment. We here describe the paradoxical use of antioxidants and supplements during cancer therapy, possible interactions with anticancer drugs, and the involvement of the Nrf-2 transcription factor.
补充和替代医学(CAM)补充剂在癌症患者中广泛使用。膳食补充剂、维生素和矿物质、草药疗法以及抗氧化剂尤其受欢迎。在一项系统的文献综述中,共识别出37项研究,每项研究都包含超过1000名参与者,内容涉及癌症患者使用补充和替代医学、膳食补充剂及维生素的情况。相应地,癌症患者会使用抗氧化剂,如维生素C(从2.6%(英国)到41.6%(美国))和维生素E(从2.9%(中国)到48%(美国))。服用膳食补充剂和维生素的原因各不相同,但通常是在涉及化疗或放疗的传统癌症治疗期间自行决定服用,而未向医疗保健专业人员寻求医学建议。与膳食补充剂或维生素涉及多种信号通路的药物相互作用已有详尽描述。由于大多数抗癌药物会产生活性氧(ROS),因此可以观察到健康细胞和恶性细胞主要由Nrf-2-Keap I网络驱动的适应性应激反应。一方面,应保护健康细胞免受产生过量ROS的化疗和放疗的影响;另一方面,癌细胞中ROS的产生是抗癌药物治疗期间的一种“理想副作用”。我们在此描述癌症治疗期间抗氧化剂和补充剂的矛盾使用情况、与抗癌药物可能的相互作用以及Nrf-2转录因子的参与情况。